New Omicron Subvariant BA.2

Omicron has approximately 60 mutations, it is thought that its sister lineage may have 85 mutations. The World Health Organization (WHO) stated over the weekend that this lineage differs from the original Omicron strain by several mutations, including those of the spike protein, the SARS-CoV-2 protein that mediates host cell entry. This variant has also been termed the “stealth variant” due to a mutation that renders it ‘invisible’ as Omicron to PCR testing.

BA.2 has spread to over 40 countries, including the US, UK, India, Australia, and Norway. In the latter, it currently accounts for half of Omicron cases. It is currently unknown why BA.2 has dominated so quickly in Norway; however, enhanced immune escape or transmissibility has been suggested.

Current reports liken the symptoms of the new lineage to that of the original strain of Omicron: sore throat, headaches, nausea, etc. It is believed that there are no differences in disease severity, with some even suggesting the symptoms are milder.

Scientists currently understand that previous Omicron infection confers protection against BA.2 and expect the already developed vaccines to be effective against the Omicron subvariant. Nonetheless, the WHO has made recommendations that understanding the immune escape characteristics of BA.2 is of great priority.

With reports of yet another Omicron subvariant, BA.3, it is of ever-increasing importance to track the emergence of new SARS-CoV-2 strains and understand their implications on public health.


Reference: https://www.tridhascholars.org/press-release/as-per-the-study-what-we-know-so-far-about-new-omicron-subvariant-ba-2.php




Comments

Post a Comment

Popular posts from this blog

Increased TMPRSS2 Expression in Tongue Tissue of Females and Alcohol Drinkers

A Potential Risk Factor for SARS-CoV-2 Infection Identified as Increased TMPRSS2 Expression in Tongue Tissue of Females and Alcohol Drinkers In the present study, the researchers used immunoblot analysis and immunohistochemistry techniques to determine ACE-2 and TMPRSS2 expression in the human and murine tongue tissue. Tongue,  submandibular glands , and kidneys were acquired from euthanized five-week-old male mice. Half the tissues were fixed in phosphate-buffered formalin for immunohistochemical and histological analysis, while the other half was frozen at -80 °C for the immunoblot assay. With informed consent, human tongue samples were acquired from patients with primary tongue cancer who underwent surgery. The non-tumorous regions of the tongue were fixed in formalin and embedded in paraffin for the  immunohistochemical tests . Three fresh human tongue samples were used for the immunoblot analysis. Paraffin-fixed tissues were sectioned and mounted on glass slides. Immunostaining wa
Read more

SARS-CoV-2 Infection and Nasopharyngeal Microbiota

C anadian researchers investigated how  severe acute respiratory syndrome coronavirus 2  (SARS-CoV-2) infection altered the microbiota composition of the host’s nasopharyngeal region. The risk and clinical outcomes of SARS-CoV-2 infection vary widely among individuals. However, the mechanisms underlying these differences in  coronavirus disease 2019  (COVID-19) progression and pathogenesis remain unclear. Studies have shown that the mucosal microbiome influences host toll-like receptor (TLR) expression, which is involved in virus detection. Studies have also shown the prevalence of bacterial co-infections in COVID-19 patients at 6.9%. Likewise, elevated nasal cytokines have been implicated in adverse clinical outcomes in influenza patients. Therefore, exploring upper respiratory tract microbiota compositional changes following SARS-CoV-2 infection could help evaluate its impact on  infection  severity. Overall, the study results presented a granular picture of the microbiota difference
Read more

SARS-CoV-2 Spike and Human Proteins

T he emergence and rapid outbreak of a novel coronavirus, namely,   severe acute respiratory syndrome coronavirus-2   (SARS-CoV-2) in China in 2019, caused a global pandemic, which is popularly known as the coronavirus disease 2019 pandemic (COVID-19). Some of the common symptoms of COVID-19 include cough, fever, loss of taste/smell, and shortness of breath. Additionally, many individuals infected with SARS-CoV-2 remain asymptomatic. However, some  COVID-19 patients  experience more severe complications including thrombosis, myocarditis, and thrombocytopenia. Scientists identified molecular mimicry hotspots in the S region. They revealed the presence of molecular mimics with a high autoimmune potential in clusters within the S protein of SARS-CoV-2. Researchers observed that some clusters contained many molecular mimics whose motifs are found in human proteins.  Molecular mimics  present in the α-helices exhibited higher structural similarity based on the normal conformation of the hel
Read more